Royalty Pharma PLC (RPRX)
27.82
-0.01
(-0.04%)
USD |
NASDAQ |
Apr 23, 16:00
Royalty Pharma Profit Margin (Quarterly): 82.93% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 82.93% |
| September 30, 2023 | 13.45% |
| June 30, 2023 | 42.29% |
| March 31, 2023 | 49.82% |
| December 31, 2022 | -80.62% |
| September 30, 2022 | 24.88% |
| June 30, 2022 | 56.82% |
| March 31, 2022 | 9.21% |
| December 31, 2021 | 1.37% |
| September 30, 2021 | 17.40% |
| Date | Value |
|---|---|
| June 30, 2021 | 79.42% |
| March 31, 2021 | 12.06% |
| December 31, 2020 | 29.90% |
| September 30, 2020 | 53.98% |
| June 30, 2020 | 86.52% |
| March 31, 2020 | 14.22% |
| December 31, 2019 | |
| September 30, 2019 | 88.09% |
| June 30, 2019 | 33.15% |
| March 31, 2019 | 84.49% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-80.62%
Minimum
Dec 2022
88.09%
Maximum
Sep 2019
34.16%
Average
31.53%
Median
Profit Margin (Quarterly) Benchmarks
| Viatris Inc | -19.95% |
| Walgreens Boots Alliance Inc | -15.95% |
| Pacira BioSciences Inc | 13.72% |
| Amphastar Pharmaceuticals Inc | 20.31% |
| Maravai LifeSciences Holdings Inc | -142.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.62% |
| Return on Assets | 6.82% |
| Return on Invested Capital | 6.88% |